Publications

In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

 63
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

Tags:

Previous Article

Molecular mechanisms of endometriosis and comorbidities

Next Article

Predicting if multiple sclerosis medication will be effective for patients

Related Posts

Portal vein-enriched metabolites as intermediate regulators of the gut microbiome in insulin resistance

Portal vein-enriched metabolites as intermediate regula...

 141

Is criticality a unified setpoint of brain function?

Is criticality a unified setpoint of brain function?

 67

Parallels and crosstalk of ADP-ribosylation and ubiquitination

Parallels and crosstalk of ADP-ribosylation and ubiquit...

 55